Protein,Protein_definition,Disease_category,Disease,NB_individual,NB_case,OR[95%CI],P_value
CELSR2,Cadherin EGF LAG seven-pass G-type receptor 2,Chapter I Certain infectious and parasitic diseases,Certain infectious and parasitic diseases,20720,854,1.73 [1.39-2.16],1.262920519853222e-06
CELSR2,Cadherin EGF LAG seven-pass G-type receptor 2,Chapter I Certain infectious and parasitic diseases,Implicit bacterial Sepsis,20670,167,3.52 [2.33-5.32],2.3743207380512726e-09
CELSR2,Cadherin EGF LAG seven-pass G-type receptor 2,Chapter I Certain infectious and parasitic diseases,Intestinal infectious diseases,22361,167,1.40 [0.85-2.29],0.1852649190256514
CELSR2,Cadherin EGF LAG seven-pass G-type receptor 2,Chapter I Certain infectious and parasitic diseases,Implicit Sepsis,15761,639,2.19 [1.70-2.81],1.3516580178347759e-09
CELSR2,Cadherin EGF LAG seven-pass G-type receptor 2,Chapter I Certain infectious and parasitic diseases,Other bacterial intestinal infections,22303,109,1.33 [0.72-2.45],0.3640463873313579
CELSR2,Cadherin EGF LAG seven-pass G-type receptor 2,Chapter I Certain infectious and parasitic diseases,Explicit Sepsis,21424,74,4.11 [2.40-7.02],2.426155512828959e-07
CELSR2,Cadherin EGF LAG seven-pass G-type receptor 2,Chapter I Certain infectious and parasitic diseases,"Bacterial intestinal infections, IBD co-morbidities",23507,108,1.34 [0.73-2.47],0.3451400681900182
CELSR2,Cadherin EGF LAG seven-pass G-type receptor 2,Chapter I Certain infectious and parasitic diseases,Other specified/unspecified bacterial intestinal infections,23500,71,1.14 [0.53-2.44],0.7455392932540412
CELSR2,Cadherin EGF LAG seven-pass G-type receptor 2,Chapter I Certain infectious and parasitic diseases,Implicit viral Sepsis,20884,50,3.95 [2.15-7.27],9.801969434878022e-06
CELSR2,Cadherin EGF LAG seven-pass G-type receptor 2,Chapter I Certain infectious and parasitic diseases,Other bacterial diseases,22956,104,3.39 [2.09-5.49],7.43465768363395e-07
CELSR2,Cadherin EGF LAG seven-pass G-type receptor 2,Chapter I Certain infectious and parasitic diseases,Other septicaemia,22916,64,4.27 [2.47-7.36],1.9410836348954814e-07
CELSR2,Cadherin EGF LAG seven-pass G-type receptor 2,Chapter I Certain infectious and parasitic diseases,Viral infections characterized by skin and mucous membrane lesions,23573,68,1.42 [0.65-3.08],0.3746434989293463
CELSR2,Cadherin EGF LAG seven-pass G-type receptor 2,Chapter I Certain infectious and parasitic diseases,Other viral diseases,23548,83,2.10 [1.10-3.99],0.0241972804794108
CELSR2,Cadherin EGF LAG seven-pass G-type receptor 2,Chapter I Certain infectious and parasitic diseases,"Other viral diseases, not elsewhere classified",23545,80,2.05 [1.06-3.96],0.0332707731236788
CELSR2,Cadherin EGF LAG seven-pass G-type receptor 2,Chapter I Certain infectious and parasitic diseases,Mycoses,23255,59,2.06 [0.98-4.34],0.0578499881669077
CELSR2,Cadherin EGF LAG seven-pass G-type receptor 2,Chapter I Certain infectious and parasitic diseases,"Bacterial, viral and other infectious agents",22567,370,1.81 [1.31-2.50],0.0003474128789478
CELSR2,Cadherin EGF LAG seven-pass G-type receptor 2,Chapter I Certain infectious and parasitic diseases,Streptococcus and staphylococcus as the cause of diseases classified to other chapters,22311,114,2.20 [1.27-3.81],0.0046478611022626
CELSR2,Cadherin EGF LAG seven-pass G-type receptor 2,Chapter I Certain infectious and parasitic diseases,Other bacterial agents as the cause of diseases classified to other chapters,22454,257,1.72 [1.17-2.54],0.0061009901093826
CELSR2,Cadherin EGF LAG seven-pass G-type receptor 2,Chapter II Neoplasms,"Malignant neoplasm of colon, excluding all cancers (controls excluding all cancers)",19272,46,1.34 [0.51-3.49],0.5547680352816164
CELSR2,Cadherin EGF LAG seven-pass G-type receptor 2,Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",19281,55,nan [nan-nan],
CELSR2,Cadherin EGF LAG seven-pass G-type receptor 2,Chapter II Neoplasms,"Other malignant neoplasms of skin (=non-melanoma skin cancer), excluding all cancers (controls excluding all cancers)",19455,229,0.77 [0.49-1.21],0.2569100876504269
CELSR2,Cadherin EGF LAG seven-pass G-type receptor 2,Chapter II Neoplasms,"Squamous cell neoplasms and carcinomas of the skin, excluding all cancers (controls excluding all cancers)",19462,236,0.79 [0.50-1.23],0.2977470013373505
CELSR2,Cadherin EGF LAG seven-pass G-type receptor 2,Chapter II Neoplasms,"Malignant neoplasm of breast, excluding all cancers (controls excluding all cancers)",19801,575,6.75 [5.32-8.58],5.178923490653659e-55
CELSR2,Cadherin EGF LAG seven-pass G-type receptor 2,Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",19271,45,3.23 [1.63-6.42],0.0008177512947314
CELSR2,Cadherin EGF LAG seven-pass G-type receptor 2,Chapter III Diseases of the blood and blood-forming organs and certain disorders involving the immune mechanism,Diseases of the blood and blood-forming organs and certain disorders involving the immune mechanism,21163,873,1.52 [1.22-1.90],0.0002045582449339
CELSR2,Cadherin EGF LAG seven-pass G-type receptor 2,Chapter II Neoplasms,"Benign neoplasm of colon, rectum, anus and anal canal",22664,250,0.87 [0.57-1.32],0.5082894430316958
CELSR2,Cadherin EGF LAG seven-pass G-type receptor 2,Chapter II Neoplasms,Benign neoplasm: Sigmoid colon,23271,95,1.01 [0.52-1.97],0.9760015784931348
CELSR2,Cadherin EGF LAG seven-pass G-type receptor 2,Chapter II Neoplasms,"Benign neoplasm: Colon, unspecified",23653,82,0.50 [0.24-1.05],0.067282052420883
CELSR2,Cadherin EGF LAG seven-pass G-type receptor 2,Chapter II Neoplasms,Benign neoplasm: Rectum,23473,54,1.29 [0.55-3.03],0.5641861943255528
CELSR2,Cadherin EGF LAG seven-pass G-type receptor 2,Chapter II Neoplasms,Benign neoplasm of other and ill-defined parts of digestive system,23655,58,1.28 [0.55-2.95],0.567322826599169
CELSR2,Cadherin EGF LAG seven-pass G-type receptor 2,Chapter II Neoplasms,Benign neoplasm: Stomach,23697,44,1.72 [0.69-4.28],0.242611343666227
CELSR2,Cadherin EGF LAG seven-pass G-type receptor 2,Chapter II Neoplasms,Benign lipomatous neoplasm,23509,240,0.98 [0.64-1.49],0.9096401211958032
CELSR2,Cadherin EGF LAG seven-pass G-type receptor 2,Chapter II Neoplasms,Benign lipomatous neoplasm of skin and subcutaneous tissue of trunk,23654,98,0.88 [0.45-1.73],0.7073961584520347
CELSR2,Cadherin EGF LAG seven-pass G-type receptor 2,Chapter II Neoplasms,Benign lipomatous neoplasm of skin and subcutaneous tissue of limbs,23653,90,0.99 [0.49-1.97],0.967801341656376
CELSR2,Cadherin EGF LAG seven-pass G-type receptor 2,Chapter II Neoplasms,"Haemangioma and lymphangioma, any site",23590,61,1.29 [0.57-2.94],0.5392294583211246
CELSR2,Cadherin EGF LAG seven-pass G-type receptor 2,Chapter II Neoplasms,"Haemangioma, any site",23592,60,1.30 [0.57-2.98],0.5335686926171825
CELSR2,Cadherin EGF LAG seven-pass G-type receptor 2,Chapter II Neoplasms,Melanocytic naevi,23508,231,0.87 [0.56-1.36],0.5382399828764693
CELSR2,Cadherin EGF LAG seven-pass G-type receptor 2,Chapter II Neoplasms,Melanocytic naevi of other and unspecified parts of face,23657,109,1.02 [0.54-1.93],0.950276149629705
CELSR2,Cadherin EGF LAG seven-pass G-type receptor 2,Chapter II Neoplasms,Other benign neoplasms of skin,23564,195,1.26 [0.79-2.00],0.3339653603383771
CELSR2,Cadherin EGF LAG seven-pass G-type receptor 2,Chapter II Neoplasms,Benign neoplasm of breast,23642,120,0.91 [0.49-1.67],0.7625120197903101
CELSR2,Cadherin EGF LAG seven-pass G-type receptor 2,Chapter II Neoplasms,Leiomyoma of uterus,23212,870,0.88 [0.70-1.11],0.2674418784029838
CELSR2,Cadherin EGF LAG seven-pass G-type receptor 2,Chapter III Diseases of the blood and blood-forming organs and certain disorders involving the immune mechanism,Other and unspecified iron deficiency,22525,238,1.77 [1.19-2.65],0.0053022052181706
CELSR2,Cadherin EGF LAG seven-pass G-type receptor 2,Chapter III Diseases of the blood and blood-forming organs and certain disorders involving the immune mechanism,Other anaemias,22293,375,2.07 [1.51-2.83],5.022461656944242e-06
CELSR2,Cadherin EGF LAG seven-pass G-type receptor 2,Chapter III Diseases of the blood and blood-forming organs and certain disorders involving the immune mechanism,Other and unspecified anaemias,22293,375,2.07 [1.51-2.83],5.022461656944242e-06
CELSR2,Cadherin EGF LAG seven-pass G-type receptor 2,Chapter I Certain infectious and parasitic diseases,Condition for Implicit Sepsis (Organ dysfunction codes),20983,338,2.33 [1.68-3.22],3.054865449306291e-07
CELSR2,Cadherin EGF LAG seven-pass G-type receptor 2,Chapter III Diseases of the blood and blood-forming organs and certain disorders involving the immune mechanism,Agranulocytosis,23187,83,2.59 [1.42-4.74],0.0020041933463738
CELSR2,Cadherin EGF LAG seven-pass G-type receptor 2,"Chapter IV Endocrine, nutritional and metabolic diseases",Disorders of other endocrine glands,23404,83,1.95 [0.99-3.84],0.0521892850450692
CELSR2,Cadherin EGF LAG seven-pass G-type receptor 2,"Chapter IV Endocrine, nutritional and metabolic diseases",Metabolic disorders,19704,753,1.92 [1.52-2.42],4.205245134540852e-08
CELSR2,Cadherin EGF LAG seven-pass G-type receptor 2,"Chapter IV Endocrine, nutritional and metabolic diseases",Disorders of the thyroid gland,21740,760,1.19 [0.94-1.51],0.1580140089401441
CELSR2,Cadherin EGF LAG seven-pass G-type receptor 2,"Chapter IV Endocrine, nutritional and metabolic diseases",Type 1 diabetes,22113,97,1.64 [0.87-3.06],0.1239232142773148
CELSR2,Cadherin EGF LAG seven-pass G-type receptor 2,Chapter IX Diseases of the circulatory system,Peripheral artery disease,22812,47,2.17 [0.97-4.88],0.0605419599976966
CELSR2,Cadherin EGF LAG seven-pass G-type receptor 2,"Chapter IV Endocrine, nutritional and metabolic diseases",Type 1 diabetes without complications,22103,87,1.64 [0.84-3.19],0.1442833487321511
CELSR2,Cadherin EGF LAG seven-pass G-type receptor 2,"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes,22361,345,1.59 [1.13-2.23],0.0074862627055956
CELSR2,Cadherin EGF LAG seven-pass G-type receptor 2,"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,22351,335,1.46 [1.03-2.07],0.0344433754266967
CELSR2,Cadherin EGF LAG seven-pass G-type receptor 2,"Chapter IV Endocrine, nutritional and metabolic diseases",Obesity,21938,164,1.73 [1.00-3.00],0.0494683908099468
CELSR2,Cadherin EGF LAG seven-pass G-type receptor 2,"Chapter IV Endocrine, nutritional and metabolic diseases","Obesity, other/unspecified",21940,161,1.81 [1.05-3.15],0.0339647735385174
CELSR2,Cadherin EGF LAG seven-pass G-type receptor 2,"Chapter IV Endocrine, nutritional and metabolic diseases",Disorders of lipoprotein metabolism and other lipidaemias,19539,588,1.86 [1.43-2.41],3.473376520194836e-06
CELSR2,Cadherin EGF LAG seven-pass G-type receptor 2,"Chapter IV Endocrine, nutritional and metabolic diseases","Hyperlipidaemia, other/unspecified",19017,66,3.07 [1.74-5.41],0.0001109895530952
CELSR2,Cadherin EGF LAG seven-pass G-type receptor 2,"Chapter IV Endocrine, nutritional and metabolic diseases",Pure hypercholesterolaemia,19499,548,1.74 [1.32-2.28],6.648937541572259e-05
CELSR2,Cadherin EGF LAG seven-pass G-type receptor 2,"Chapter IV Endocrine, nutritional and metabolic diseases",Volume depletion,18999,48,4.63 [2.61-8.20],1.5743359453263532e-07
CELSR2,Cadherin EGF LAG seven-pass G-type receptor 2,"Chapter IV Endocrine, nutritional and metabolic diseases","Other disorders of fluid, electrolyte and acid-base balance",19009,58,2.47 [1.27-4.80],0.0078371414229023
CELSR2,Cadherin EGF LAG seven-pass G-type receptor 2,Chapter V Mental and behavioural disorders,Any mental disorder,19987,515,1.14 [0.85-1.53],0.3861333359757779
CELSR2,Cadherin EGF LAG seven-pass G-type receptor 2,Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",19568,96,0.95 [0.48-1.88],0.8896236777612194
CELSR2,Cadherin EGF LAG seven-pass G-type receptor 2,Chapter V Mental and behavioural disorders,"Mental and behavioural disorders due to alcohol, excluding acute intoxication",23481,61,1.02 [0.44-2.34],0.9693080770525752
CELSR2,Cadherin EGF LAG seven-pass G-type receptor 2,Chapter V Mental and behavioural disorders,"Alcohol use disorder, ICD-based",23517,36,1.15 [0.39-3.33],0.801494648888604
CELSR2,Cadherin EGF LAG seven-pass G-type receptor 2,Chapter V Mental and behavioural disorders,Acute alcohol intoxication,22445,31,0.69 [0.21-2.29],0.54252334396124
CELSR2,Cadherin EGF LAG seven-pass G-type receptor 2,Chapter V Mental and behavioural disorders,"Acute alcohol intoxication, ICD10",23653,31,0.68 [0.21-2.26],0.5320070133321827
CELSR2,Cadherin EGF LAG seven-pass G-type receptor 2,Chapter V Mental and behavioural disorders,"Alcohol abuse, main dg, excluding more controls",19503,31,0.68 [0.20-2.28],0.5319514389892013
CELSR2,Cadherin EGF LAG seven-pass G-type receptor 2,Chapter V Mental and behavioural disorders,Alcohol dependence,22435,21,1.29 [0.33-5.10],0.7154843328622795
CELSR2,Cadherin EGF LAG seven-pass G-type receptor 2,Chapter V Mental and behavioural disorders,Smoking dependency,22355,31,1.08 [0.35-3.35],0.8939033728649984
CELSR2,Cadherin EGF LAG seven-pass G-type receptor 2,Chapter V Mental and behavioural disorders,"Schizophrenia or delusion, excluding more controls",19510,38,0.73 [0.25-2.17],0.5705714494290932
CELSR2,Cadherin EGF LAG seven-pass G-type receptor 2,Chapter V Mental and behavioural disorders,"Mood disorders, excluding more controls",19788,316,1.42 [0.99-2.04],0.0563766517650944
CELSR2,Cadherin EGF LAG seven-pass G-type receptor 2,Chapter V Mental and behavioural disorders,Depression,21979,282,1.52 [1.04-2.22],0.031104798735773
CELSR2,Cadherin EGF LAG seven-pass G-type receptor 2,Chapter V Mental and behavioural disorders,Depression or dysthymia,19609,244,1.33 [0.88-2.01],0.179694657629811
CELSR2,Cadherin EGF LAG seven-pass G-type receptor 2,Chapter V Mental and behavioural disorders,"Anxiety disorders, excluding more controls",19600,128,1.39 [0.78-2.47],0.2574710286577641
CELSR2,Cadherin EGF LAG seven-pass G-type receptor 2,Chapter V Mental and behavioural disorders,Other anxiety disorders,22050,65,0.98 [0.43-2.24],0.9678570839143374
CELSR2,Cadherin EGF LAG seven-pass G-type receptor 2,Chapter VI Diseases of the nervous system,Neurological diseases,20508,1392,1.06 [0.88-1.28],0.5192087266468163
CELSR2,Cadherin EGF LAG seven-pass G-type receptor 2,Chapter VI Diseases of the nervous system,Other degenerative diseases of the nervous system,18760,158,0.48 [0.28-0.83],0.008919541607287
CELSR2,Cadherin EGF LAG seven-pass G-type receptor 2,Chapter VI Diseases of the nervous system,MS-disease / Multiple Sclerosis,23525,129,0.51 [0.28-0.94],0.0297729647675273
CELSR2,Cadherin EGF LAG seven-pass G-type receptor 2,Chapter VI Diseases of the nervous system,Episodal and paroxysmal disorders,22570,364,1.30 [0.92-1.82],0.1356877046803921
CELSR2,Cadherin EGF LAG seven-pass G-type receptor 2,Chapter VI Diseases of the nervous system,Epilepsy,22319,113,0.77 [0.41-1.44],0.4060744328803124
CELSR2,Cadherin EGF LAG seven-pass G-type receptor 2,Chapter VI Diseases of the nervous system,Migraine,22315,109,1.16 [0.62-2.18],0.6395286110285321
CELSR2,Cadherin EGF LAG seven-pass G-type receptor 2,Chapter VI Diseases of the nervous system,"Migraine, unspecified, drug-induced",23317,102,1.06 [0.55-2.04],0.8540916720147224
CELSR2,Cadherin EGF LAG seven-pass G-type receptor 2,Chapter IX Diseases of the circulatory system,Transient ischemic attack,23101,50,2.95 [1.51-5.78],0.0016034240001441
CELSR2,Cadherin EGF LAG seven-pass G-type receptor 2,Chapter VI Diseases of the nervous system,Other sleep disorders,22294,88,1.45 [0.73-2.87],0.2858288240821126
CELSR2,Cadherin EGF LAG seven-pass G-type receptor 2,Chapter VI Diseases of the nervous system,Sleep apnoea,23342,62,1.34 [0.59-3.04],0.487900695355561
CELSR2,Cadherin EGF LAG seven-pass G-type receptor 2,Chapter VI Diseases of the nervous system,"Nerve, nerve root and plexus disorders",22503,721,1.04 [0.81-1.34],0.7504088623207055
CELSR2,Cadherin EGF LAG seven-pass G-type receptor 2,Chapter VI Diseases of the nervous system,"Other and unspecified nerve root and plexus disorders, also in other diseases",21886,104,2.50 [1.44-4.33],0.001092205571226
CELSR2,Cadherin EGF LAG seven-pass G-type receptor 2,Chapter VI Diseases of the nervous system,Carpal tunnel syndrome,22236,454,0.91 [0.66-1.24],0.5493681059102442
CELSR2,Cadherin EGF LAG seven-pass G-type receptor 2,Chapter VI Diseases of the nervous system,Cerebral palsy and other paralytic syndromes,23475,65,0.87 [0.38-1.99],0.7433025540553813
CELSR2,Cadherin EGF LAG seven-pass G-type receptor 2,Chapter VI Diseases of the nervous system,Hemiplegia,23458,48,0.86 [0.33-2.22],0.7493598650509941
CELSR2,Cadherin EGF LAG seven-pass G-type receptor 2,Chapter VI Diseases of the nervous system,Other neurological diseases,23279,101,1.27 [0.67-2.41],0.4682432502321374
CELSR2,Cadherin EGF LAG seven-pass G-type receptor 2,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Disorders of eyelid, lacrimal system and orbit",23064,372,0.79 [0.56-1.11],0.1778111127068523
CELSR2,Cadherin EGF LAG seven-pass G-type receptor 2,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Other disorders of eyelid,22905,213,0.78 [0.50-1.23],0.290086889739833
CELSR2,Cadherin EGF LAG seven-pass G-type receptor 2,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Chalazion,22755,63,0.32 [0.14-0.75],0.0084969040433066
CELSR2,Cadherin EGF LAG seven-pass G-type receptor 2,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Other specified and unspecified  disorders of eyelid,22803,111,0.68 [0.36-1.28],0.227254780166624
CELSR2,Cadherin EGF LAG seven-pass G-type receptor 2,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Disorders of lacrimal system,22785,93,0.99 [0.50-1.95],0.9754444813354995
CELSR2,Cadherin EGF LAG seven-pass G-type receptor 2,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Senile cataract,20100,145,1.49 [0.90-2.47],0.1207917390798952
CELSR2,Cadherin EGF LAG seven-pass G-type receptor 2,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Other cataract,20311,356,1.00 [0.71-1.42],0.9946975119322702
CELSR2,Cadherin EGF LAG seven-pass G-type receptor 2,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Disorders of choroid and retina,22809,153,1.73 [1.07-2.81],0.026461514461737
CELSR2,Cadherin EGF LAG seven-pass G-type receptor 2,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Background diabetic retinopathy,23479,28,2.65 [1.00-7.02],0.049915448293544
CELSR2,Cadherin EGF LAG seven-pass G-type receptor 2,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Diabetic maculopathy,1530,28,2.28 [0.80-6.45],0.1220905180395889
CELSR2,Cadherin EGF LAG seven-pass G-type receptor 2,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic maculopathy, excluding more controls",21977,28,2.68 [1.02-7.05],0.0451266081915747
CELSR2,Cadherin EGF LAG seven-pass G-type receptor 2,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Glaucoma,23093,80,0.93 [0.45-1.93],0.8427832050950531
CELSR2,Cadherin EGF LAG seven-pass G-type receptor 2,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Other and unspecified glaucoma,23056,43,0.48 [0.17-1.33],0.1557629275431979
CELSR2,Cadherin EGF LAG seven-pass G-type receptor 2,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Disorders of ocular muscles, binocular movement, accommodation and refraction",22970,76,0.74 [0.34-1.61],0.4507892740066702
CELSR2,Cadherin EGF LAG seven-pass G-type receptor 2,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual disturbances,23201,88,0.71 [0.35-1.45],0.3460262608967756
CELSR2,Cadherin EGF LAG seven-pass G-type receptor 2,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Diseases of middle ear and mastoid,23589,110,1.46 [0.80-2.66],0.2143833686447323
CELSR2,Cadherin EGF LAG seven-pass G-type receptor 2,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Other disorders of ear,23013,93,1.35 [0.70-2.60],0.375310595379455
CELSR2,Cadherin EGF LAG seven-pass G-type receptor 2,Chapter IX Diseases of the circulatory system,Death due to cardiac causes,17410,2362,1.62 [1.39-1.89],1.12002641352786e-09
CELSR2,Cadherin EGF LAG seven-pass G-type receptor 2,Chapter IX Diseases of the circulatory system,Rheumatic valve diseases,23219,65,2.36 [1.24-4.50],0.0092415408599514
CELSR2,Cadherin EGF LAG seven-pass G-type receptor 2,Chapter IX Diseases of the circulatory system,"Hypertension, essential",18329,1734,1.60 [1.35-1.91],1.0416957470549781e-07
CELSR2,Cadherin EGF LAG seven-pass G-type receptor 2,Chapter IX Diseases of the circulatory system,Hypertension,18344,1749,1.68 [1.42-2.00],3.387981832022255e-09
CELSR2,Cadherin EGF LAG seven-pass G-type receptor 2,Chapter IX Diseases of the circulatory system,Hypertensive Renal Disease,16629,34,,
CELSR2,Cadherin EGF LAG seven-pass G-type receptor 2,Chapter IX Diseases of the circulatory system,"Ischaemic heart disease, wide definition",22275,616,1.58 [1.22-2.04],0.0005035422837888
CELSR2,Cadherin EGF LAG seven-pass G-type receptor 2,Chapter IX Diseases of the circulatory system,Angina pectoris,22086,427,1.47 [1.08-1.99],0.0145010072212277
CELSR2,Cadherin EGF LAG seven-pass G-type receptor 2,Chapter IX Diseases of the circulatory system,Unstable angina pectoris,23122,123,1.06 [0.59-1.89],0.8520378101932504
CELSR2,Cadherin EGF LAG seven-pass G-type receptor 2,Chapter IX Diseases of the circulatory system,Major coronary heart disease event,23190,191,1.59 [1.03-2.46],0.0382870504024157
CELSR2,Cadherin EGF LAG seven-pass G-type receptor 2,Chapter IX Diseases of the circulatory system,"Myocardial infarction, with ST-elevation",23637,25,1.92 [0.61-6.04],0.2620685417326868
CELSR2,Cadherin EGF LAG seven-pass G-type receptor 2,Chapter IX Diseases of the circulatory system,"Myocardial infarction, strict",21740,81,2.95 [1.73-5.06],7.953012214505647e-05
CELSR2,Cadherin EGF LAG seven-pass G-type receptor 2,Chapter IX Diseases of the circulatory system,Coronary atherosclerosis,22043,395,1.60 [1.17-2.20],0.0035444668124728
CELSR2,Cadherin EGF LAG seven-pass G-type receptor 2,Chapter IX Diseases of the circulatory system,Pulmonary embolism,23018,83,2.49 [1.38-4.48],0.0023160387812175
CELSR2,Cadherin EGF LAG seven-pass G-type receptor 2,Chapter IX Diseases of the circulatory system,Venous thromboembolism,23116,185,1.45 [0.91-2.31],0.1156143665705899
CELSR2,Cadherin EGF LAG seven-pass G-type receptor 2,Chapter IX Diseases of the circulatory system,Secondary right heart disease,23025,90,3.44 [2.07-5.70],1.7034661187540014e-06
CELSR2,Cadherin EGF LAG seven-pass G-type receptor 2,Chapter IX Diseases of the circulatory system,Other pulmonary heart/vessel disease,23025,90,3.44 [2.07-5.70],1.7034661187540014e-06
CELSR2,Cadherin EGF LAG seven-pass G-type receptor 2,Chapter IX Diseases of the circulatory system,"Hypertension, Pulmonary Arterial",16682,87,3.48 [2.07-5.86],2.5957679263364225e-06
CELSR2,Cadherin EGF LAG seven-pass G-type receptor 2,Chapter IX Diseases of the circulatory system,Cardiomyopathy,20602,31,3.08 [1.44-6.57],0.0036955726266008
CELSR2,Cadherin EGF LAG seven-pass G-type receptor 2,Chapter IX Diseases of the circulatory system,Conduction disorders,20634,63,1.37 [0.61-3.05],0.4434371714135605
CELSR2,Cadherin EGF LAG seven-pass G-type receptor 2,Chapter IX Diseases of the circulatory system,Paroxysmal tachycardia,14234,83,0.87 [0.41-1.85],0.7237304073976196
CELSR2,Cadherin EGF LAG seven-pass G-type receptor 2,Chapter IX Diseases of the circulatory system,Atrial fibrillation and flutter,14383,232,2.36 [1.60-3.49],1.5410483827102575e-05
CELSR2,Cadherin EGF LAG seven-pass G-type receptor 2,Chapter IX Diseases of the circulatory system,Other arrhythmias,20614,43,1.17 [0.44-3.17],0.751343817685135
CELSR2,Cadherin EGF LAG seven-pass G-type receptor 2,Chapter IX Diseases of the circulatory system,Other or ill-defined heart diseases,20620,49,2.47 [1.16-5.27],0.0189552237595589
CELSR2,Cadherin EGF LAG seven-pass G-type receptor 2,Chapter IX Diseases of the circulatory system,"Heart failure, strict",22991,85,4.79 [2.87-7.98],1.971765181650586e-09
CELSR2,Cadherin EGF LAG seven-pass G-type receptor 2,Chapter IX Diseases of the circulatory system,"Stroke, including SAH",23025,110,1.23 [0.66-2.28],0.5131781794371799
CELSR2,Cadherin EGF LAG seven-pass G-type receptor 2,Chapter IX Diseases of the circulatory system,"Stroke, excluding SAH",23061,82,1.23 [0.61-2.51],0.5616886003442567
CELSR2,Cadherin EGF LAG seven-pass G-type receptor 2,Chapter IX Diseases of the circulatory system,"Ischaemic Stroke, excluding all haemorrhages",23121,70,1.12 [0.51-2.43],0.7794392041283733
CELSR2,Cadherin EGF LAG seven-pass G-type receptor 2,Chapter IX Diseases of the circulatory system,Other diseases of arteries and capillaries,22837,60,1.88 [0.87-4.04],0.1075221959812477
CELSR2,Cadherin EGF LAG seven-pass G-type receptor 2,Chapter IX Diseases of the circulatory system,Other peripheral vascular diseases,22872,95,1.25 [0.65-2.41],0.5086810898107768
CELSR2,Cadherin EGF LAG seven-pass G-type receptor 2,Chapter IX Diseases of the circulatory system,Phlebitis and thrombophlebitis (not including DVT),22316,112,0.97 [0.52-1.82],0.9287671135572232
CELSR2,Cadherin EGF LAG seven-pass G-type receptor 2,Chapter IX Diseases of the circulatory system,DVT of lower extremities,22293,89,1.22 [0.61-2.42],0.5777178051201215
CELSR2,Cadherin EGF LAG seven-pass G-type receptor 2,Chapter IX Diseases of the circulatory system,"!Phlebitis/thrombophlebitis venae iliacae [externae/internae/communis], drug-induced",23507,88,1.26 [0.63-2.49],0.515570947004888
CELSR2,Cadherin EGF LAG seven-pass G-type receptor 2,Chapter IX Diseases of the circulatory system,Varicose veins,22728,524,0.71 [0.52-0.95],0.021864308688088
CELSR2,Cadherin EGF LAG seven-pass G-type receptor 2,Chapter IX Diseases of the circulatory system,Hypotension,22752,73,1.60 [0.79-3.28],0.1950014622353214
CELSR2,Cadherin EGF LAG seven-pass G-type receptor 2,Chapter X Diseases of the respiratory system,Diseases of the respiratory system,19258,1822,1.18 [1.01-1.39],0.0416871267781352
CELSR2,Cadherin EGF LAG seven-pass G-type receptor 2,Chapter X Diseases of the respiratory system,Acute upper respiratory infections,23511,113,2.32 [1.34-4.00],0.0025688788385147
CELSR2,Cadherin EGF LAG seven-pass G-type receptor 2,Chapter X Diseases of the respiratory system,Influenza and pneumonia,22293,179,2.04 [1.32-3.15],0.0014077535299601
CELSR2,Cadherin EGF LAG seven-pass G-type receptor 2,Chapter X Diseases of the respiratory system,"Pneumonia, organism unspecified",22276,162,2.05 [1.30-3.24],0.0020005514707341
CELSR2,Cadherin EGF LAG seven-pass G-type receptor 2,Chapter X Diseases of the respiratory system,Other acute lower respiratory infections,22900,205,1.10 [0.70-1.74],0.6768461816460708
CELSR2,Cadherin EGF LAG seven-pass G-type receptor 2,Chapter X Diseases of the respiratory system,Unspecified acute lower respiratory infection,22895,200,1.09 [0.69-1.73],0.7118154252506688
CELSR2,Cadherin EGF LAG seven-pass G-type receptor 2,Chapter X Diseases of the respiratory system,Other diseases of upper respiratory tract,23033,484,0.95 [0.70-1.29],0.7450331249162077
CELSR2,Cadherin EGF LAG seven-pass G-type receptor 2,Chapter X Diseases of the respiratory system,Chronic sinusitis,22652,103,0.94 [0.49-1.79],0.8397749243342554
CELSR2,Cadherin EGF LAG seven-pass G-type receptor 2,Chapter X Diseases of the respiratory system,Nasal polyp,22620,71,1.15 [0.54-2.48],0.7163781045694314
CELSR2,Cadherin EGF LAG seven-pass G-type receptor 2,Chapter X Diseases of the respiratory system,"Diseases of vocal cords and larynx+other diseases of upper respiratory tract, no elsewhere classified",22856,307,0.88 [0.60-1.29],0.5242992202907449
CELSR2,Cadherin EGF LAG seven-pass G-type receptor 2,Chapter X Diseases of the respiratory system,Deviated nasal septum,22670,121,1.22 [0.68-2.21],0.5031766804322477
CELSR2,Cadherin EGF LAG seven-pass G-type receptor 2,Chapter X Diseases of the respiratory system,Vocal cord dysfunction,11374,56,1.48 [0.65-3.38],0.3532306830510889
CELSR2,Cadherin EGF LAG seven-pass G-type receptor 2,Chapter X Diseases of the respiratory system,Chronic lower respiratory diseases,21123,1004,1.07 [0.87-1.33],0.5228003047542892
CELSR2,Cadherin EGF LAG seven-pass G-type receptor 2,Chapter X Diseases of the respiratory system,Early onset COPD,22795,136,1.60 [0.95-2.71],0.077981712361319
CELSR2,Cadherin EGF LAG seven-pass G-type receptor 2,Chapter X Diseases of the respiratory system,"COPD, hospital admissions 1, only main diagnosis",22812,153,1.58 [0.96-2.59],0.0690380587357899
CELSR2,Cadherin EGF LAG seven-pass G-type receptor 2,Chapter X Diseases of the respiratory system,"Other chronic obstructive pulmonary disease, including avohilmo",22812,153,1.58 [0.96-2.59],0.0690380587357899
CELSR2,Cadherin EGF LAG seven-pass G-type receptor 2,Chapter X Diseases of the respiratory system,"Asthma, hospital admissions , main diagnosis only",21896,859,0.99 [0.78-1.24],0.9094449087286374
CELSR2,Cadherin EGF LAG seven-pass G-type receptor 2,Chapter X Diseases of the respiratory system,Asthma,17585,859,1.05 [0.83-1.33],0.6728701633363641
CELSR2,Cadherin EGF LAG seven-pass G-type receptor 2,Chapter X Diseases of the respiratory system,"Asthma, excluding more controls",17425,859,1.06 [0.84-1.34],0.6165160449353875
CELSR2,Cadherin EGF LAG seven-pass G-type receptor 2,Chapter X Diseases of the respiratory system,"Asthma, unspecified (mode)",17573,847,1.05 [0.83-1.33],0.6584493347140926
CELSR2,Cadherin EGF LAG seven-pass G-type receptor 2,Chapter X Diseases of the respiratory system,Other respiratory diseases principally affecting the interstitium,23412,79,2.59 [1.44-4.67],0.001487161778067
CELSR2,Cadherin EGF LAG seven-pass G-type receptor 2,Chapter X Diseases of the respiratory system,Interstitial lung disease,22116,61,2.06 [0.99-4.28],0.0535486662183104
CELSR2,Cadherin EGF LAG seven-pass G-type receptor 2,Chapter X Diseases of the respiratory system,"ILD, hospital admissions",23474,61,2.04 [0.98-4.23],0.0557649203406908
CELSR2,Cadherin EGF LAG seven-pass G-type receptor 2,Chapter X Diseases of the respiratory system,Idiopathic pulmonary fibrosis,22109,54,2.11 [0.98-4.56],0.0568434707321612
CELSR2,Cadherin EGF LAG seven-pass G-type receptor 2,Chapter X Diseases of the respiratory system,Pleural effusion,22106,74,2.03 [1.03-3.99],0.0404728012120984
CELSR2,Cadherin EGF LAG seven-pass G-type receptor 2,Chapter X Diseases of the respiratory system,Other diseases of pleura,22199,167,2.31 [1.49-3.58],0.0001769479069411
CELSR2,Cadherin EGF LAG seven-pass G-type receptor 2,Chapter X Diseases of the respiratory system,Other respiratory disorders and diseases,22684,79,3.28 [1.91-5.64],1.646560555511574e-05
CELSR2,Cadherin EGF LAG seven-pass G-type receptor 2,Chapter XI Diseases of the digestive system,Gastrointestinal diseases,16466,5178,1.06 [0.94-1.19],0.3249566484613677
CELSR2,Cadherin EGF LAG seven-pass G-type receptor 2,Chapter XI Diseases of the digestive system,"Diseases of oral cavity, salivary glands and jaws",23203,406,1.06 [0.76-1.47],0.7254286691916163
CELSR2,Cadherin EGF LAG seven-pass G-type receptor 2,Chapter XI Diseases of the digestive system,Embedded and impacted teeth,23657,85,1.37 [0.67-2.79],0.3914259814383553
CELSR2,Cadherin EGF LAG seven-pass G-type receptor 2,Chapter XI Diseases of the digestive system,Impacted teeth,23662,77,1.21 [0.57-2.58],0.625854220414876
CELSR2,Cadherin EGF LAG seven-pass G-type receptor 2,Chapter XI Diseases of the digestive system,Dental caries,22891,94,0.78 [0.39-1.54],0.4680452092987955
CELSR2,Cadherin EGF LAG seven-pass G-type receptor 2,Chapter XI Diseases of the digestive system,Diseases of pulp and periapical tissues,22902,105,0.90 [0.47-1.73],0.759567139023861
CELSR2,Cadherin EGF LAG seven-pass G-type receptor 2,Chapter XI Diseases of the digestive system,Palatinal maxillary canine,23648,94,1.30 [0.65-2.56],0.4567752508753925
CELSR2,Cadherin EGF LAG seven-pass G-type receptor 2,Chapter XI Diseases of the digestive system,Other disorders of teeth and supporting structures,22892,95,0.94 [0.48-1.85],0.8547249528968428
CELSR2,Cadherin EGF LAG seven-pass G-type receptor 2,Chapter XI Diseases of the digestive system,Other diseases of lip and oral mucosa,22640,66,0.30 [0.13-0.69],0.0045197545407418
CELSR2,Cadherin EGF LAG seven-pass G-type receptor 2,Chapter XI Diseases of the digestive system,Oral lichen ruber planus,23578,43,0.27 [0.10-0.73],0.0101360964194738
CELSR2,Cadherin EGF LAG seven-pass G-type receptor 2,Chapter XI Diseases of the digestive system,Gastroduodenal ulcer,17925,192,1.02 [0.63-1.63],0.9469454909415592
CELSR2,Cadherin EGF LAG seven-pass G-type receptor 2,Chapter XI Diseases of the digestive system,"Diseases of oesophagus, stomach and duodenum",19727,1994,1.07 [0.92-1.26],0.3692582339254188
CELSR2,Cadherin EGF LAG seven-pass G-type receptor 2,Chapter XI Diseases of the digestive system,Oesophagitis,17983,250,1.22 [0.81-1.84],0.3414703284342482
CELSR2,Cadherin EGF LAG seven-pass G-type receptor 2,Chapter XI Diseases of the digestive system,Gastro-oesophageal reflux disease,18381,648,1.11 [0.85-1.45],0.4264928171840152
CELSR2,Cadherin EGF LAG seven-pass G-type receptor 2,Chapter XI Diseases of the digestive system,Other diseases of oesophagus,17800,67,0.55 [0.24-1.26],0.157871911736067
CELSR2,Cadherin EGF LAG seven-pass G-type receptor 2,Chapter XI Diseases of the digestive system,Ulcer of oesophagus,17850,117,1.86 [1.05-3.27],0.0322157826519776
CELSR2,Cadherin EGF LAG seven-pass G-type receptor 2,Chapter XI Diseases of the digestive system,Oesophageal obstruction,17767,34,1.33 [0.45-3.90],0.6089088626537502
CELSR2,Cadherin EGF LAG seven-pass G-type receptor 2,Chapter XI Diseases of the digestive system,Gastric ulcer,17861,128,1.28 [0.73-2.26],0.3907341980999423
CELSR2,Cadherin EGF LAG seven-pass G-type receptor 2,Chapter XI Diseases of the digestive system,Duodenal ulcer,17798,65,0.72 [0.31-1.65],0.4355940331852801
CELSR2,Cadherin EGF LAG seven-pass G-type receptor 2,Chapter XI Diseases of the digestive system,"Duodenal ulcer - Unspecified as acute or chronic, without haemorrhage or perforation, drug-induced",23616,51,0.30 [0.12-0.77],0.0122060487278761
CELSR2,Cadherin EGF LAG seven-pass G-type receptor 2,Chapter XI Diseases of the digestive system,Chronic gastritis,17847,114,1.13 [0.62-2.07],0.6926757620311472
CELSR2,Cadherin EGF LAG seven-pass G-type receptor 2,Chapter XI Diseases of the digestive system,Other gastritis (incl. Duodenitis),18456,723,1.19 [0.93-1.53],0.1645495295844132
CELSR2,Cadherin EGF LAG seven-pass G-type receptor 2,Chapter XI Diseases of the digestive system,Diseases of appendix,23555,133,1.15 [0.65-2.03],0.6360779972238759
CELSR2,Cadherin EGF LAG seven-pass G-type receptor 2,Chapter XI Diseases of the digestive system,Functional dyspepsia,18229,496,0.92 [0.68-1.24],0.5725557360413487
CELSR2,Cadherin EGF LAG seven-pass G-type receptor 2,Chapter XI Diseases of the digestive system,Other diseases of stomach and duodenum,17883,150,1.06 [0.62-1.81],0.8363172524907853
CELSR2,Cadherin EGF LAG seven-pass G-type receptor 2,Chapter XI Diseases of the digestive system,Colonic or urogenital fistula,23575,125,0.89 [0.49-1.62],0.7097304788164402
CELSR2,Cadherin EGF LAG seven-pass G-type receptor 2,Chapter XI Diseases of the digestive system,Acute appendicitis,23532,110,1.17 [0.62-2.19],0.6305769115522399
CELSR2,Cadherin EGF LAG seven-pass G-type receptor 2,Chapter XI Diseases of the digestive system,Hernia,21224,1047,1.01 [0.82-1.25],0.9000818189435218
CELSR2,Cadherin EGF LAG seven-pass G-type receptor 2,Chapter XI Diseases of the digestive system,Inguinal hernia,20235,58,0.53 [0.22-1.30],0.1670142253187092
CELSR2,Cadherin EGF LAG seven-pass G-type receptor 2,Chapter XI Diseases of the digestive system,Umbilical hernia,20244,67,1.28 [0.58-2.82],0.5335698896095336
CELSR2,Cadherin EGF LAG seven-pass G-type receptor 2,Chapter XI Diseases of the digestive system,Ventral hernia,20266,89,1.12 [0.57-2.23],0.7408959792092564
CELSR2,Cadherin EGF LAG seven-pass G-type receptor 2,Chapter XI Diseases of the digestive system,Diaphragmatic hernia,21014,837,1.11 [0.88-1.40],0.3871771892271893
CELSR2,Cadherin EGF LAG seven-pass G-type receptor 2,Chapter XI Diseases of the digestive system,Noninfective enteritis and colitis,22760,795,1.34 [1.06-1.69],0.0128868471293235
CELSR2,Cadherin EGF LAG seven-pass G-type receptor 2,Chapter XI Diseases of the digestive system,Other diseases of intestines,18800,1885,1.07 [0.91-1.26],0.3837834316738926
CELSR2,Cadherin EGF LAG seven-pass G-type receptor 2,Chapter XI Diseases of the digestive system,"Crohn disease (strict definition, all UC cases excluded)",23399,54,1.24 [0.51-3.01],0.6381759357299975
CELSR2,Cadherin EGF LAG seven-pass G-type receptor 2,Chapter XI Diseases of the digestive system,"Crohn disease (strict definition, require KELA, min 2 HDR)",23637,77,1.18 [0.56-2.49],0.6613620569980385
CELSR2,Cadherin EGF LAG seven-pass G-type receptor 2,Chapter XI Diseases of the digestive system,Crohn disease,22042,77,1.21 [0.57-2.55],0.6199651280798724
CELSR2,Cadherin EGF LAG seven-pass G-type receptor 2,Chapter XI Diseases of the digestive system,Crohn's disease NAS,22021,56,2.11 [0.96-4.66],0.0648382099179745
CELSR2,Cadherin EGF LAG seven-pass G-type receptor 2,Chapter XI Diseases of the digestive system,"Ulcerative colitis (strict definition, require KELA, min 2 HDR)",23564,112,1.26 [0.68-2.32],0.4594589551674926
CELSR2,Cadherin EGF LAG seven-pass G-type receptor 2,Chapter XI Diseases of the digestive system,Ulcerative colitis,22077,112,1.29 [0.70-2.38],0.4119653611948263
CELSR2,Cadherin EGF LAG seven-pass G-type receptor 2,Chapter XI Diseases of the digestive system,"Ulcerative colitis, NAS",22063,98,1.27 [0.66-2.45],0.4734697664046693
CELSR2,Cadherin EGF LAG seven-pass G-type receptor 2,Chapter XI Diseases of the digestive system,Other noninfective gastroenteritis and colitis,22644,679,1.29 [1.00-1.65],0.049683090793578
CELSR2,Cadherin EGF LAG seven-pass G-type receptor 2,Chapter XI Diseases of the digestive system,Noninfectious colitis NAS,22634,669,1.28 [0.99-1.64],0.0593902228430625
CELSR2,Cadherin EGF LAG seven-pass G-type receptor 2,Chapter XI Diseases of the digestive system,Paralytic ileus and intestinal obstruction,17001,86,1.37 [0.68-2.73],0.3770401783187046
CELSR2,Cadherin EGF LAG seven-pass G-type receptor 2,Chapter XI Diseases of the digestive system,Intestinal stricture,23285,86,1.31 [0.66-2.60],0.4452322540886796
CELSR2,Cadherin EGF LAG seven-pass G-type receptor 2,Chapter XI Diseases of the digestive system,"Other or unspecified ileus, impaction or obstruction",16968,53,0.89 [0.35-2.24],0.7996447531346637
CELSR2,Cadherin EGF LAG seven-pass G-type receptor 2,Chapter XI Diseases of the digestive system,Diverticular disease of intestine,17495,580,1.14 [0.87-1.51],0.3480392605247285
CELSR2,Cadherin EGF LAG seven-pass G-type receptor 2,Chapter XI Diseases of the digestive system,Irritable bowel syndrome,17124,209,0.72 [0.45-1.15],0.1698439989291864
CELSR2,Cadherin EGF LAG seven-pass G-type receptor 2,Chapter XI Diseases of the digestive system,Other functional intestinal disorders,17241,326,1.34 [0.94-1.93],0.1065133858080676
CELSR2,Cadherin EGF LAG seven-pass G-type receptor 2,Chapter XI Diseases of the digestive system,Constipation,22252,291,1.30 [0.89-1.90],0.1717168854623088
CELSR2,Cadherin EGF LAG seven-pass G-type receptor 2,Chapter XI Diseases of the digestive system,Diseases of peritoneum,23244,104,1.07 [0.56-2.05],0.832584542653759
CELSR2,Cadherin EGF LAG seven-pass G-type receptor 2,Chapter XI Diseases of the digestive system,Fissure and fistula of anal and rectal regions,17025,110,0.89 [0.46-1.71],0.7223818842543759
CELSR2,Cadherin EGF LAG seven-pass G-type receptor 2,Chapter XI Diseases of the digestive system,Abscess of anal and rectal regions,16954,39,0.52 [0.17-1.54],0.2364489793256223
CELSR2,Cadherin EGF LAG seven-pass G-type receptor 2,Chapter XI Diseases of the digestive system,Other diseases of anus and rectum,17694,779,1.07 [0.84-1.37],0.5724345749449032
CELSR2,Cadherin EGF LAG seven-pass G-type receptor 2,Chapter XI Diseases of the digestive system,Other diseases of intestine,17116,201,0.91 [0.57-1.46],0.7031292068954883
CELSR2,Cadherin EGF LAG seven-pass G-type receptor 2,Chapter XI Diseases of the digestive system,Other diseases of peritoneum,23230,90,1.00 [0.49-2.02],0.996151009715062
CELSR2,Cadherin EGF LAG seven-pass G-type receptor 2,Chapter XI Diseases of the digestive system,Diseases of liver,23024,89,2.67 [1.53-4.67],0.0005562543214995
CELSR2,Cadherin EGF LAG seven-pass G-type receptor 2,Chapter XI Diseases of the digestive system,Other diseases of liver,22982,47,2.83 [1.33-6.03],0.0071913871285143
CELSR2,Cadherin EGF LAG seven-pass G-type receptor 2,Chapter XI Diseases of the digestive system,"Disorders of gallbladder, biliary tract and pancreas",22346,744,1.23 [0.96-1.56],0.0978894074393048
CELSR2,Cadherin EGF LAG seven-pass G-type receptor 2,Chapter XI Diseases of the digestive system,Cholelithiasis,22224,622,1.15 [0.88-1.50],0.2962003801990549
CELSR2,Cadherin EGF LAG seven-pass G-type receptor 2,Chapter XI Diseases of the digestive system,Cholecystitis,21716,114,1.13 [0.62-2.09],0.6837939969687975
CELSR2,Cadherin EGF LAG seven-pass G-type receptor 2,Chapter XI Diseases of the digestive system,Other diseases of biliary tract,21660,58,2.31 [1.13-4.74],0.0218076669773738
CELSR2,Cadherin EGF LAG seven-pass G-type receptor 2,Chapter XI Diseases of the digestive system,Acute pancreatitis,21654,52,1.70 [0.74-3.92],0.2107845291004947
CELSR2,Cadherin EGF LAG seven-pass G-type receptor 2,Chapter XI Diseases of the digestive system,Acute pancreatitis (for exclusion),23556,52,1.67 [0.72-3.85],0.2313654255492483
CELSR2,Cadherin EGF LAG seven-pass G-type receptor 2,Chapter XI Diseases of the digestive system,Diseases of the digestive system,22512,254,1.02 [0.68-1.55],0.9201151794653608
CELSR2,Cadherin EGF LAG seven-pass G-type receptor 2,Chapter XI Diseases of the digestive system,Intestinal malabsorption,22344,86,0.81 [0.39-1.66],0.5612644021253822
CELSR2,Cadherin EGF LAG seven-pass G-type receptor 2,Chapter XI Diseases of the digestive system,Coeliac disease,22331,73,0.98 [0.45-2.13],0.959196634714796
CELSR2,Cadherin EGF LAG seven-pass G-type receptor 2,Chapter XI Diseases of the digestive system,"Postprocedural disorders of digestive system, not elsewhere classified",22292,34,0.89 [0.28-2.80],0.8473148508383433
CELSR2,Cadherin EGF LAG seven-pass G-type receptor 2,Chapter XI Diseases of the digestive system,Other diseases of the digestive system,22397,139,1.06 [0.61-1.84],0.8361219793569673
CELSR2,Cadherin EGF LAG seven-pass G-type receptor 2,Chapter XI Diseases of the digestive system,GI-bleeding,22389,131,1.08 [0.61-1.91],0.7826905139308259
CELSR2,Cadherin EGF LAG seven-pass G-type receptor 2,Chapter XII Diseases of the skin and subcutaneous tissue,Diseases of the skin and subcutaneous tissue,20972,1385,0.99 [0.82-1.19],0.9080337096967536
CELSR2,Cadherin EGF LAG seven-pass G-type receptor 2,Chapter XII Diseases of the skin and subcutaneous tissue,Dermatitis and eczema,23298,103,1.14 [0.60-2.16],0.6903965481507494
CELSR2,Cadherin EGF LAG seven-pass G-type receptor 2,Chapter XII Diseases of the skin and subcutaneous tissue,Disorders of skin appendages,23311,386,1.02 [0.72-1.42],0.9298848618566964
CELSR2,Cadherin EGF LAG seven-pass G-type receptor 2,Chapter XII Diseases of the skin and subcutaneous tissue,Other disorders of skin and subcutaneous tissue,22323,592,0.95 [0.72-1.25],0.7085904986861652
CELSR2,Cadherin EGF LAG seven-pass G-type receptor 2,Chapter XII Diseases of the skin and subcutaneous tissue,Infections of the skin and subcutaneous tissue,22977,284,1.02 [0.69-1.51],0.9291969843810988
CELSR2,Cadherin EGF LAG seven-pass G-type receptor 2,Chapter XII Diseases of the skin and subcutaneous tissue,"Cutaneous abscess, furuncle and carbuncle",22756,63,0.43 [0.18-1.00],0.0491405422779622
CELSR2,Cadherin EGF LAG seven-pass G-type receptor 2,Chapter XII Diseases of the skin and subcutaneous tissue,Cellulitis,22876,183,1.35 [0.84-2.18],0.209795530729255
CELSR2,Cadherin EGF LAG seven-pass G-type receptor 2,Chapter XII Diseases of the skin and subcutaneous tissue,Papulosquamous disorders,23435,75,1.72 [0.85-3.46],0.1294371084142949
CELSR2,Cadherin EGF LAG seven-pass G-type receptor 2,Chapter XII Diseases of the skin and subcutaneous tissue,Psoriasis,23414,54,2.48 [1.18-5.19],0.0162542167121443
CELSR2,Cadherin EGF LAG seven-pass G-type receptor 2,Chapter XII Diseases of the skin and subcutaneous tissue,Other and unspecified psoriasis,23402,42,2.81 [1.27-6.22],0.0107467370120227
CELSR2,Cadherin EGF LAG seven-pass G-type receptor 2,Chapter XII Diseases of the skin and subcutaneous tissue,Radiation-related disorders of the skin and subcutaneous tissue,23472,49,1.09 [0.44-2.74],0.851759373281482
CELSR2,Cadherin EGF LAG seven-pass G-type receptor 2,Chapter XII Diseases of the skin and subcutaneous tissue,Skin changes due to chronic exposure to nonionizing radiation,23469,46,1.04 [0.40-2.70],0.9365377680906348
CELSR2,Cadherin EGF LAG seven-pass G-type receptor 2,Chapter XII Diseases of the skin and subcutaneous tissue,Nail disorders,22976,51,2.35 [1.11-5.01],0.0264210646058882
CELSR2,Cadherin EGF LAG seven-pass G-type receptor 2,Chapter XII Diseases of the skin and subcutaneous tissue,Follicular cysts of skin and subcutaneous tissue,23225,300,0.96 [0.66-1.42],0.8529860382868697
CELSR2,Cadherin EGF LAG seven-pass G-type receptor 2,Chapter XII Diseases of the skin and subcutaneous tissue,Seborrhoeic keratosis,21817,86,0.59 [0.29-1.23],0.1590878320327815
CELSR2,Cadherin EGF LAG seven-pass G-type receptor 2,Chapter XII Diseases of the skin and subcutaneous tissue,Atrophic disorders of skin,21861,130,1.05 [0.59-1.88],0.8689744782504959
CELSR2,Cadherin EGF LAG seven-pass G-type receptor 2,Chapter XII Diseases of the skin and subcutaneous tissue,Scar conditions and fibrosis of skin,21827,96,1.39 [0.72-2.66],0.3268099257964693
CELSR2,Cadherin EGF LAG seven-pass G-type receptor 2,Chapter XII Diseases of the skin and subcutaneous tissue,"Other disorders of skin and subcutaneous tissue, not elsewhere classified",21950,219,0.90 [0.57-1.42],0.6578094400055505
CELSR2,Cadherin EGF LAG seven-pass G-type receptor 2,Chapter XII Diseases of the skin and subcutaneous tissue,Other and unspecified disorders of skin and subcutaneous tissue,21929,198,0.90 [0.56-1.45],0.6680133470923808
CELSR2,Cadherin EGF LAG seven-pass G-type receptor 2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Diseases of the musculoskeletal system and connective tissue,16688,3804,1.03 [0.91-1.17],0.6515528475650236
CELSR2,Cadherin EGF LAG seven-pass G-type receptor 2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Arthropathies,18195,2191,0.91 [0.78-1.06],0.2217837477185908
CELSR2,Cadherin EGF LAG seven-pass G-type receptor 2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Soft tissue disorders,21265,1144,1.02 [0.83-1.24],0.8648128880389291
CELSR2,Cadherin EGF LAG seven-pass G-type receptor 2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Rheumatoid arthritis,16197,193,1.20 [0.75-1.92],0.4494263136355507
CELSR2,Cadherin EGF LAG seven-pass G-type receptor 2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Polyarthropathies,16456,452,1.04 [0.76-1.42],0.8085560632401189
CELSR2,Cadherin EGF LAG seven-pass G-type receptor 2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,"Other (seronegative) rheumatoid arthritis, wide",23195,185,1.21 [0.75-1.95],0.42491989528464
CELSR2,Cadherin EGF LAG seven-pass G-type receptor 2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Other/unspecified rheumatoid arthritis,23209,170,1.37 [0.84-2.22],0.2101899918308258
CELSR2,Cadherin EGF LAG seven-pass G-type receptor 2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Arthrosis,17053,1049,0.82 [0.66-1.02],0.0756718139811963
CELSR2,Cadherin EGF LAG seven-pass G-type receptor 2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,"Artrosis, including avohilmo",19402,1049,0.81 [0.65-1.01],0.0556096059922137
CELSR2,Cadherin EGF LAG seven-pass G-type receptor 2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Gout,16016,12,7.80 [2.60-23.37],0.0002467745330069
CELSR2,Cadherin EGF LAG seven-pass G-type receptor 2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,"Gout, unspecified",23534,12,6.42 [2.46-16.76],0.0001453536885527
CELSR2,Cadherin EGF LAG seven-pass G-type receptor 2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Other specified/unspecified arthritis,16235,231,0.65 [0.41-1.01],0.0559316579403962
CELSR2,Cadherin EGF LAG seven-pass G-type receptor 2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Polyarthrosis,16081,77,0.53 [0.24-1.14],0.1039348441074964
CELSR2,Cadherin EGF LAG seven-pass G-type receptor 2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Coxarthrosis,16268,264,0.67 [0.44-1.02],0.0626382042241748
CELSR2,Cadherin EGF LAG seven-pass G-type receptor 2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,"Coxarthrosis, primary",23513,134,0.61 [0.34-1.09],0.0938123848877569
CELSR2,Cadherin EGF LAG seven-pass G-type receptor 2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Gonarthrosis,16412,408,0.75 [0.53-1.06],0.1064949614010284
CELSR2,Cadherin EGF LAG seven-pass G-type receptor 2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Other arthrosis,16414,410,1.15 [0.82-1.59],0.4177299535656578
CELSR2,Cadherin EGF LAG seven-pass G-type receptor 2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Other joint disorders,17230,1226,0.96 [0.79-1.17],0.6979785982251475
CELSR2,Cadherin EGF LAG seven-pass G-type receptor 2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Other deformities of toe(s),16103,99,0.94 [0.48-1.85],0.8675015641229873
CELSR2,Cadherin EGF LAG seven-pass G-type receptor 2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Hallux valgus (acquired),16364,360,0.92 [0.64-1.31],0.6442335705906606
CELSR2,Cadherin EGF LAG seven-pass G-type receptor 2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Hallux rigidus,16072,68,0.97 [0.43-2.17],0.9355842191842212
CELSR2,Cadherin EGF LAG seven-pass G-type receptor 2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Other hammer toe(s) (acquired),16095,91,0.82 [0.40-1.66],0.5769128347697692
CELSR2,Cadherin EGF LAG seven-pass G-type receptor 2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Internal derangement of knee,16325,321,1.14 [0.78-1.65],0.5059489822059022
CELSR2,Cadherin EGF LAG seven-pass G-type receptor 2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Meniscus derangement,16276,272,1.05 [0.70-1.57],0.8307184090747646
CELSR2,Cadherin EGF LAG seven-pass G-type receptor 2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Pain in joint,17640,256,0.99 [0.65-1.49],0.9461814687288324
CELSR2,Cadherin EGF LAG seven-pass G-type receptor 2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Systemic lupus erythematosus,22965,206,1.08 [0.68-1.71],0.7337077025279666
CELSR2,Cadherin EGF LAG seven-pass G-type receptor 2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Other systemic involvement of connective tissue,22842,83,2.31 [1.29-4.16],0.0050837550391571
CELSR2,Cadherin EGF LAG seven-pass G-type receptor 2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Deforming dorsopathies,20271,76,2.54 [1.41-4.58],0.0018441998646726
CELSR2,Cadherin EGF LAG seven-pass G-type receptor 2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Spondylopathies,20462,267,1.44 [0.98-2.11],0.0623222339145274
CELSR2,Cadherin EGF LAG seven-pass G-type receptor 2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Dorsopathies,21092,897,1.26 [1.01-1.57],0.0389945839068757
CELSR2,Cadherin EGF LAG seven-pass G-type receptor 2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Spondylosis,20379,184,1.24 [0.77-1.99],0.3739335455452693
CELSR2,Cadherin EGF LAG seven-pass G-type receptor 2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Spinal stenosis,20262,67,1.18 [0.54-2.57],0.6785873804905871
CELSR2,Cadherin EGF LAG seven-pass G-type receptor 2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,"Other dorsopathies, not elsewhere classified",20911,716,1.17 [0.92-1.50],0.2035079134978579
CELSR2,Cadherin EGF LAG seven-pass G-type receptor 2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Cervical disc disorders,20237,42,1.21 [0.44-3.33],0.7084405816000425
CELSR2,Cadherin EGF LAG seven-pass G-type receptor 2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Other intervertebral disc disorders,20410,215,1.73 [1.14-2.63],0.010052966299209
CELSR2,Cadherin EGF LAG seven-pass G-type receptor 2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Lumbar disc prolapse,20287,92,1.87 [0.99-3.51],0.0528344126523811
CELSR2,Cadherin EGF LAG seven-pass G-type receptor 2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Sciatica+with lumbago,20270,75,0.68 [0.31-1.47],0.3226067439701459
CELSR2,Cadherin EGF LAG seven-pass G-type receptor 2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Other/unspecified dorsalgia,20325,130,1.07 [0.60-1.90],0.8177175702663847
CELSR2,Cadherin EGF LAG seven-pass G-type receptor 2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Cervicalgia,20265,70,0.58 [0.26-1.29],0.1790706140993913
CELSR2,Cadherin EGF LAG seven-pass G-type receptor 2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Low back pain,20505,310,1.34 [0.93-1.93],0.1161517036234369
CELSR2,Cadherin EGF LAG seven-pass G-type receptor 2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Disorders of synovium and tendon,20454,333,0.72 [0.50-1.04],0.0797988354235988
CELSR2,Cadherin EGF LAG seven-pass G-type receptor 2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Other/unspecified synovitis and tenosynovitis,20184,63,0.79 [0.34-1.83],0.5766954401960036
CELSR2,Cadherin EGF LAG seven-pass G-type receptor 2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Trigger finger,20215,94,0.70 [0.35-1.40],0.3092482735254743
CELSR2,Cadherin EGF LAG seven-pass G-type receptor 2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Ganglion,20242,121,0.63 [0.34-1.16],0.1355894438447344
CELSR2,Cadherin EGF LAG seven-pass G-type receptor 2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,"Soft tissue disorders related to use, overuse and pressure",20157,36,0.37 [0.12-1.15],0.0853910270816276
CELSR2,Cadherin EGF LAG seven-pass G-type receptor 2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Fibroblastic disorders,20171,50,1.32 [0.53-3.28],0.5503971025075303
CELSR2,Cadherin EGF LAG seven-pass G-type receptor 2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Palmar fascial fibromatosis [Dupuytren],20158,37,1.97 [0.75-5.21],0.1706970190162513
CELSR2,Cadherin EGF LAG seven-pass G-type receptor 2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Shoulder lesions,20349,228,1.05 [0.68-1.62],0.8221518948852818
CELSR2,Cadherin EGF LAG seven-pass G-type receptor 2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Other shoulder lesions,20172,51,1.09 [0.44-2.71],0.8480544372815592
CELSR2,Cadherin EGF LAG seven-pass G-type receptor 2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Rotator cuff syndrome,20174,53,1.58 [0.70-3.59],0.2743327139067648
CELSR2,Cadherin EGF LAG seven-pass G-type receptor 2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Impingement syndrome of shoulder,20234,113,0.66 [0.35-1.24],0.1963731597620048
CELSR2,Cadherin EGF LAG seven-pass G-type receptor 2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Other enthesopathies,20190,69,1.01 [0.45-2.24],0.9852473104642768
CELSR2,Cadherin EGF LAG seven-pass G-type receptor 2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,"Other soft tissue disorders, not elsewhere classified",20588,467,1.30 [0.96-1.76],0.0864928171676833
CELSR2,Cadherin EGF LAG seven-pass G-type receptor 2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Other specified/unspecified soft tissue disorders,20287,166,1.43 [0.87-2.35],0.1607674480151928
CELSR2,Cadherin EGF LAG seven-pass G-type receptor 2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Pain in limb,20374,253,1.13 [0.75-1.72],0.5580985216316174
CELSR2,Cadherin EGF LAG seven-pass G-type receptor 2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Osteoporosis,21323,212,1.18 [0.75-1.83],0.4760414056117814
CELSR2,Cadherin EGF LAG seven-pass G-type receptor 2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Osteopathies and chondropathies,21526,415,1.25 [0.91-1.72],0.1657403548776083
CELSR2,Cadherin EGF LAG seven-pass G-type receptor 2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Disorders of continuity of bone,21145,34,2.06 [0.75-5.71],0.1631175925450565
CELSR2,Cadherin EGF LAG seven-pass G-type receptor 2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Other specified/unspecified disorders of  bone/cartilage,21160,49,1.04 [0.40-2.68],0.937229213458844
CELSR2,Cadherin EGF LAG seven-pass G-type receptor 2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Other disorders of bone,21202,91,1.14 [0.57-2.28],0.706509294172451
CELSR2,Cadherin EGF LAG seven-pass G-type receptor 2,Chapter XIV Diseases of the genitourinary system,Genitourinary diseases,19446,5297,1.17 [1.05-1.30],0.004702023979687
CELSR2,Cadherin EGF LAG seven-pass G-type receptor 2,Chapter XIV Diseases of the genitourinary system,Renal tubulo-interstitial diseases,21698,158,8.12 [5.52-11.93],1.544643562838721e-26
CELSR2,Cadherin EGF LAG seven-pass G-type receptor 2,Chapter XIV Diseases of the genitourinary system,Other obstructive and reflux uropathy,21579,39,4.18 [2.09-8.37],5.262728251528308e-05
CELSR2,Cadherin EGF LAG seven-pass G-type receptor 2,Chapter XIV Diseases of the genitourinary system,Acute renal failure,21863,26,,
CELSR2,Cadherin EGF LAG seven-pass G-type receptor 2,Chapter XIV Diseases of the genitourinary system,Chronic kidney disease,21867,30,,
CELSR2,Cadherin EGF LAG seven-pass G-type receptor 2,Chapter XIV Diseases of the genitourinary system,Unspecified kidney failure,21870,33,8.80 [4.62-16.77],3.6866728266961423e-11
CELSR2,Cadherin EGF LAG seven-pass G-type receptor 2,Chapter XIV Diseases of the genitourinary system,Urolithiasis,23484,109,1.36 [0.73-2.50],0.331901500035311
CELSR2,Cadherin EGF LAG seven-pass G-type receptor 2,Chapter XIV Diseases of the genitourinary system,Other disorders of kidney and ureter,23387,53,3.99 [2.23-7.13],3.1793990589235312e-06
CELSR2,Cadherin EGF LAG seven-pass G-type receptor 2,Chapter XIV Diseases of the genitourinary system,Calculus of kidney and ureter,23457,82,1.59 [0.80-3.17],0.1844732635352798
CELSR2,Cadherin EGF LAG seven-pass G-type receptor 2,Chapter XIV Diseases of the genitourinary system,Unspecified renal colic,23406,31,0.81 [0.24-2.71],0.7384950087618916
CELSR2,Cadherin EGF LAG seven-pass G-type receptor 2,Chapter XIV Diseases of the genitourinary system,Other diseases of urinary system,21822,1091,1.12 [0.91-1.38],0.272029615002443
CELSR2,Cadherin EGF LAG seven-pass G-type receptor 2,Chapter XIV Diseases of the genitourinary system,Cystitis,20840,109,2.11 [1.22-3.66],0.0074826607649432
CELSR2,Cadherin EGF LAG seven-pass G-type receptor 2,Chapter XIV Diseases of the genitourinary system,Neuromuscular dysfunction of bladder,20807,76,0.87 [0.40-1.87],0.7155119924970295
CELSR2,Cadherin EGF LAG seven-pass G-type receptor 2,Chapter XIV Diseases of the genitourinary system,Other disorders of  bladder,20872,141,1.35 [0.78-2.31],0.2800439196255158
CELSR2,Cadherin EGF LAG seven-pass G-type receptor 2,Chapter XIV Diseases of the genitourinary system,Urethral stricture,20812,81,1.77 [0.90-3.48],0.0960421392165649
CELSR2,Cadherin EGF LAG seven-pass G-type receptor 2,Chapter XIV Diseases of the genitourinary system,Other disorders of urethra and urinary system,21594,863,1.06 [0.84-1.34],0.6053253920948736
CELSR2,Cadherin EGF LAG seven-pass G-type receptor 2,Chapter XIV Diseases of the genitourinary system,Disorders of breast,23431,416,1.88 [1.39-2.53],4.116520774002908e-05
CELSR2,Cadherin EGF LAG seven-pass G-type receptor 2,Chapter XIV Diseases of the genitourinary system,Benign mammary dysplasia,23145,130,1.99 [1.19-3.34],0.0088561767494428
CELSR2,Cadherin EGF LAG seven-pass G-type receptor 2,Chapter XIV Diseases of the genitourinary system,Unspecified lump in breast,23159,144,1.99 [1.21-3.26],0.0063723162641046
CELSR2,Cadherin EGF LAG seven-pass G-type receptor 2,Chapter XIV Diseases of the genitourinary system,Other disorders of breast,23113,98,1.49 [0.78-2.81],0.2251882962629068
CELSR2,Cadherin EGF LAG seven-pass G-type receptor 2,Chapter XIV Diseases of the genitourinary system,Inflammatory diseases of female pelvic organs,23369,484,0.88 [0.65-1.20],0.4217598685416833
CELSR2,Cadherin EGF LAG seven-pass G-type receptor 2,Chapter XIV Diseases of the genitourinary system,Inflammatory disease of cervix uteri,23003,118,0.72 [0.39-1.34],0.3058597685828448
CELSR2,Cadherin EGF LAG seven-pass G-type receptor 2,Chapter XIV Diseases of the genitourinary system,Other female pelvic inflammatory diseases,23100,215,0.90 [0.57-1.42],0.6524055426169625
CELSR2,Cadherin EGF LAG seven-pass G-type receptor 2,Chapter XIV Diseases of the genitourinary system,Noninflammatory disorders of female genital tract,21619,3960,0.91 [0.81-1.02],0.1161652380916707
CELSR2,Cadherin EGF LAG seven-pass G-type receptor 2,Chapter XIV Diseases of the genitourinary system,Endometriosis,17960,301,1.23 [0.83-1.81],0.3001266298999161
CELSR2,Cadherin EGF LAG seven-pass G-type receptor 2,Chapter XIV Diseases of the genitourinary system,Unspecified/other endometriosis,17741,82,0.99 [0.46-2.10],0.9722228386214756
CELSR2,Cadherin EGF LAG seven-pass G-type receptor 2,Chapter XIV Diseases of the genitourinary system,Adenomyosis (Endometriosis of uterus),17801,142,1.16 [0.66-2.02],0.6093716106260909
CELSR2,Cadherin EGF LAG seven-pass G-type receptor 2,Chapter XIV Diseases of the genitourinary system,Female genital prolapse,18345,686,0.78 [0.60-1.01],0.0617149413400331
CELSR2,Cadherin EGF LAG seven-pass G-type receptor 2,Chapter XIV Diseases of the genitourinary system,Ovarian cyst,18008,349,0.70 [0.49-1.01],0.0594465390757564
CELSR2,Cadherin EGF LAG seven-pass G-type receptor 2,Chapter XIV Diseases of the genitourinary system,Polyp of the female genital tract,18480,821,0.78 [0.62-1.00],0.0482062115567988
CELSR2,Cadherin EGF LAG seven-pass G-type receptor 2,Chapter XIV Diseases of the genitourinary system,Uterine polyps,17928,269,0.67 [0.44-1.01],0.0574332184196714
CELSR2,Cadherin EGF LAG seven-pass G-type receptor 2,Chapter XIV Diseases of the genitourinary system,"Other noninflammatory disorders of uterus, except cervix",18039,380,0.95 [0.67-1.34],0.7616245173009912
CELSR2,Cadherin EGF LAG seven-pass G-type receptor 2,Chapter XIV Diseases of the genitourinary system,Erosion and ectropion of cervix uteri,17747,88,0.70 [0.34-1.47],0.3488887014874293
CELSR2,Cadherin EGF LAG seven-pass G-type receptor 2,Chapter XIV Diseases of the genitourinary system,Dysplasia of cervi uteri,17827,168,1.04 [0.62-1.75],0.8808044131919366
CELSR2,Cadherin EGF LAG seven-pass G-type receptor 2,Chapter XIV Diseases of the genitourinary system,"All dysplastic lesions of the cervix uteri, vagina or vulva",23657,229,0.96 [0.62-1.50],0.8674262326699079
CELSR2,Cadherin EGF LAG seven-pass G-type receptor 2,Chapter XIV Diseases of the genitourinary system,All dysplastic lesions of the cervix uteri,23668,217,1.01 [0.64-1.58],0.9751214252719368
CELSR2,Cadherin EGF LAG seven-pass G-type receptor 2,Chapter XIV Diseases of the genitourinary system,HSIL lesion of the cervix uteri,23689,116,1.02 [0.55-1.89],0.9572502520904438
CELSR2,Cadherin EGF LAG seven-pass G-type receptor 2,Chapter XIV Diseases of the genitourinary system,"HSIL lesion of the cervix uteri, vagina or vulva",23679,128,0.98 [0.54-1.77],0.9407990610255804
CELSR2,Cadherin EGF LAG seven-pass G-type receptor 2,Chapter XIV Diseases of the genitourinary system,Other noninflammatory disorders of cervix uteri,17787,128,0.56 [0.31-1.02],0.0601395036748321
CELSR2,Cadherin EGF LAG seven-pass G-type receptor 2,Chapter XIV Diseases of the genitourinary system,Other noninflammatory disorders of vagina,17763,104,1.78 [0.98-3.25],0.0591639917233743
CELSR2,Cadherin EGF LAG seven-pass G-type receptor 2,Chapter XIV Diseases of the genitourinary system,Other noninflammatory disorders of vulva and perineum,17783,124,0.47 [0.26-0.86],0.0152452505548177
CELSR2,Cadherin EGF LAG seven-pass G-type receptor 2,Chapter XIV Diseases of the genitourinary system,Irregular menses,23602,398,0.95 [0.68-1.34],0.7829031747991442
CELSR2,Cadherin EGF LAG seven-pass G-type receptor 2,Chapter XIV Diseases of the genitourinary system,"Excessive, frequent and irregular menstruation",18822,1163,0.92 [0.75-1.13],0.4437367729926655
CELSR2,Cadherin EGF LAG seven-pass G-type receptor 2,Chapter XIV Diseases of the genitourinary system,Menorrhagia,18423,764,0.93 [0.72-1.20],0.5640401686638741
CELSR2,Cadherin EGF LAG seven-pass G-type receptor 2,"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",23677,173,0.90 [0.54-1.50],0.6805829298889217
CELSR2,Cadherin EGF LAG seven-pass G-type receptor 2,Chapter XIV Diseases of the genitourinary system,Other abnormal uterine and vaginal bleeding,18061,402,1.14 [0.81-1.59],0.4500754712299932
CELSR2,Cadherin EGF LAG seven-pass G-type receptor 2,Chapter XIV Diseases of the genitourinary system,Pain and other conditions associated with female genital organs and menstrual cycle,17928,269,1.16 [0.77-1.75],0.4807270287139876
CELSR2,Cadherin EGF LAG seven-pass G-type receptor 2,Chapter XIV Diseases of the genitourinary system,Postmenopausal bleeding,18433,774,0.81 [0.63-1.04],0.097262054603587
CELSR2,Cadherin EGF LAG seven-pass G-type receptor 2,Chapter XIV Diseases of the genitourinary system,Female infertility,17742,83,0.93 [0.44-2.00],0.8619936712015315
CELSR2,Cadherin EGF LAG seven-pass G-type receptor 2,Chapter XIV Diseases of the genitourinary system,"Female infertility, cervigal, vaginal, other or unspecified origin",17735,76,0.88 [0.39-1.95],0.7464888448577811
CELSR2,Cadherin EGF LAG seven-pass G-type receptor 2,"Chapter XV Pregnancy, childbirth and the puerperium",Maternal care related to the fetus and amniotic cavity and possible delivery problems,23684,720,0.77 [0.58-1.02],0.0700004739774843
CELSR2,Cadherin EGF LAG seven-pass G-type receptor 2,"Chapter XV Pregnancy, childbirth and the puerperium",Complications of labour and delivery,23690,987,0.70 [0.55-0.91],0.0064851132693066
CELSR2,Cadherin EGF LAG seven-pass G-type receptor 2,"Chapter XV Pregnancy, childbirth and the puerperium",Pregnancy with abortive outcome,23684,380,1.29 [0.91-1.84],0.1501736324341826
CELSR2,Cadherin EGF LAG seven-pass G-type receptor 2,"Chapter XV Pregnancy, childbirth and the puerperium",Other abnormal products of conception,23411,107,0.90 [0.46-1.73],0.742366088986226
CELSR2,Cadherin EGF LAG seven-pass G-type receptor 2,"Chapter XV Pregnancy, childbirth and the puerperium",Spontaneous abortion,23452,148,1.47 [0.86-2.54],0.1619261096705669
CELSR2,Cadherin EGF LAG seven-pass G-type receptor 2,"Chapter XV Pregnancy, childbirth and the puerperium",Medical abortion,23441,137,1.44 [0.83-2.51],0.1984371810328651
CELSR2,Cadherin EGF LAG seven-pass G-type receptor 2,"Chapter XV Pregnancy, childbirth and the puerperium","Oedema, proteinuria and hypertensive disorders in pregnancy, childbirth and the puerperium",23701,143,0.53 [0.30-0.96],0.0376659211757788
CELSR2,Cadherin EGF LAG seven-pass G-type receptor 2,"Chapter XV Pregnancy, childbirth and the puerperium",Pregnancy hypertension,23703,140,0.53 [0.29-0.96],0.0367023825215246
CELSR2,Cadherin EGF LAG seven-pass G-type receptor 2,"Chapter XV Pregnancy, childbirth and the puerperium",Other maternal disorders predominantly related to pregnancy,23701,353,0.72 [0.49-1.05],0.0917658002089784
CELSR2,Cadherin EGF LAG seven-pass G-type receptor 2,"Chapter XV Pregnancy, childbirth and the puerperium",Haemorrhage in early pregnancy,23453,105,0.61 [0.31-1.21],0.1584306450587265
CELSR2,Cadherin EGF LAG seven-pass G-type receptor 2,"Chapter XV Pregnancy, childbirth and the puerperium",Maternal care for other conditions predominantly related to pregnancy,23544,196,0.60 [0.36-1.00],0.0484189610040243
CELSR2,Cadherin EGF LAG seven-pass G-type receptor 2,"Chapter XV Pregnancy, childbirth and the puerperium",Maternal care for known or suspected malpresentation of fetus,23087,123,0.89 [0.47-1.67],0.7146959257966391
CELSR2,Cadherin EGF LAG seven-pass G-type receptor 2,"Chapter XV Pregnancy, childbirth and the puerperium",Maternal care for known or suspected abnormality of pelvic organs,23130,166,0.69 [0.40-1.18],0.1761835083963893
CELSR2,Cadherin EGF LAG seven-pass G-type receptor 2,"Chapter XV Pregnancy, childbirth and the puerperium",Maternal care for other known or suspected fetal problems,23165,201,0.74 [0.45-1.21],0.226078398188894
CELSR2,Cadherin EGF LAG seven-pass G-type receptor 2,"Chapter XV Pregnancy, childbirth and the puerperium",Premature rupture of membranes,23086,122,0.96 [0.52-1.79],0.8968536972868868
CELSR2,Cadherin EGF LAG seven-pass G-type receptor 2,"Chapter XV Pregnancy, childbirth and the puerperium",False labour,23076,112,0.67 [0.35-1.29],0.2289302164550464
CELSR2,Cadherin EGF LAG seven-pass G-type receptor 2,"Chapter XV Pregnancy, childbirth and the puerperium",Prolonged pregnancy,23090,126,0.99 [0.53-1.84],0.9731330981872468
CELSR2,Cadherin EGF LAG seven-pass G-type receptor 2,"Chapter XV Pregnancy, childbirth and the puerperium",Long labour,22887,184,0.77 [0.45-1.32],0.3443549078701707
CELSR2,Cadherin EGF LAG seven-pass G-type receptor 2,"Chapter XV Pregnancy, childbirth and the puerperium",Labour and delivery complicated by fetal stress [distress],23068,365,0.61 [0.41-0.89],0.0103672877028578
CELSR2,Cadherin EGF LAG seven-pass G-type receptor 2,"Chapter XV Pregnancy, childbirth and the puerperium",Perineal laceration during delivery,23251,548,0.81 [0.59-1.12],0.2061923595160275
CELSR2,Cadherin EGF LAG seven-pass G-type receptor 2,"Chapter XV Pregnancy, childbirth and the puerperium","Postpartum hemorraghe, all women as controls",23705,144,0.59 [0.33-1.05],0.0736035018604771
CELSR2,Cadherin EGF LAG seven-pass G-type receptor 2,"Chapter XV Pregnancy, childbirth and the puerperium",Postpartum haemorrhage due to anatomy,22508,110,0.44 [0.23-0.86],0.0165435068264413
CELSR2,Cadherin EGF LAG seven-pass G-type receptor 2,"Chapter XV Pregnancy, childbirth and the puerperium","Other complications of labour and delivery, not elsewhere classified",22787,84,0.44 [0.20-0.94],0.0330122802824446
CELSR2,Cadherin EGF LAG seven-pass G-type receptor 2,"Chapter XV Pregnancy, childbirth and the puerperium",Delivery,23711,279,0.69 [0.45-1.05],0.0846072155762585
CELSR2,Cadherin EGF LAG seven-pass G-type receptor 2,"Chapter XV Pregnancy, childbirth and the puerperium",Single spontaneous delivery,23648,216,0.61 [0.38-0.99],0.0437328060294823
CELSR2,Cadherin EGF LAG seven-pass G-type receptor 2,"Chapter XV Pregnancy, childbirth and the puerperium","Other obstetric conditions, not elsewhere classified",23700,214,1.36 [0.85-2.17],0.1969911901522266
CELSR2,Cadherin EGF LAG seven-pass G-type receptor 2,"Chapter XV Pregnancy, childbirth and the puerperium","Other maternal diseases classifiable elsewhere but complicating pregnancy, childbirth and the puerperium",23690,204,1.40 [0.87-2.26],0.1656261090379525
CELSR2,Cadherin EGF LAG seven-pass G-type receptor 2,Chapter IX Diseases of the circulatory system,"Bradycardia, unspecified, drug-induced",23453,40,1.47 [0.57-3.80],0.4257914049582855
CELSR2,Cadherin EGF LAG seven-pass G-type receptor 2,Chapter VI Diseases of the nervous system,Falls/tendency to fall,21226,531,1.03 [0.77-1.38],0.8315123518200574
